What is NOVONIX's operating income?

NOVONIX's total operating income in 2025 was -$66.69 million, based on the following breakdown: Total Gross Profit: -$26.90 million Total Operating Expenses: $39.80 million

NOVONIX (NVX) Financials

$0.45 +0.00 (+0.38%)

Closing price 07/9/2026 03:59 PM Eastern

Extended Trading

$0.45 +0.00 (+0.22%)

As of 07:00 AM Eastern

Compare

Annual Income Statements for NOVONIX

This table shows NOVONIX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	6/30/2020	6/30/2021	6/30/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-14	-13	-52	-46	-75	-93
Consolidated Net Income / (Loss)	-13	-13	-52	-46	-75	-93
Net Income / (Loss) Continuing Operations	-14	-13	-52	-46	-75	-93
Total Pre-Tax Income	-13	-13	-52	-46	-75	-93
Total Operating Income	-13	-13	-49	-49	-54	-67
Total Gross Profit	-8.79	-5.17	-27	-20	-24	-27
Total Revenue	-1.65	0.16	-6.83	6.04	4.60	12
Operating Revenue	-2.22	-0.57	-8.43	2.43	0.33	6.76
Other Revenue	0.57	0.73	1.60	3.61	4.27	4.82
Total Cost of Revenue	7.14	5.33	20	26	29	38
Operating Cost of Revenue	7.14	5.33	20	26	29	38
Total Operating Expenses	4.53	8.21	22	29	29	40
Selling, General & Admin Expense	1.84	2.85	13	19	20	22
Research & Development Expense	1.62	2.09	5.10	5.75	4.85	5.67
Depreciation Expense	0.93	1.26	4.21	4.74	4.57	4.57
Impairment Charge	0.14	2.00	0.00	0.00	0.00	7.35
Total Other Income / (Expense), net	-0.25	-0.06	-2.92	2.89	-21	-26
Interest Expense	-	-	-	0.00	0.00	33
Interest & Investment Income	0.00	0.00	-8.11	0.00	-15	0.00
Other Income / (Expense), net	-0.25	-0.06	5.20	2.89	-5.71	6.94
Income Tax Expense	0.00	0.00	0.00	-0.20	0.10	0.03
Weighted Average Basic Shares Outstanding	135.92M	366.29M	464.44M	487.47M	496.86M	681.68M
Diluted Earnings per Share	($0.10)	($0.04)	($0.11)	($0.09)	($0.15)	($0.14)
Weighted Average Diluted Shares Outstanding	135.92M	366.29M	464.44M	487.47M	496.86M	681.68M
Weighted Average Basic & Diluted Shares Outstanding	-	-	485.95M	488.73M	488.73M	840.07M

No quarterly income statements for NOVONIX are available.

This table details how cash moves in and out of NOVONIX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	6/30/2020	6/30/2021	6/30/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	23	78	45	-19	-33	35
Net Cash From Operating Activities	-3.75	-6.09	-29	-40	-17	3.19
Net Cash From Continuing Operating Activities	-6.53	-11	-38	-40	-17	3.19
Net Income / (Loss) Continuing Operations	0.00	0.00	0.00	0.00	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	-6.53	-11	-38	-40	-16	3.91
Changes in Operating Assets and Liabilities, net	0.00	0.03	0.01	-0.30	-0.60	-0.72
Net Cash From Investing Activities	-3.69	-20	-107	-11	-17	-60
Net Cash From Continuing Investing Activities	-3.68	-20	-97	-11	-17	-60
Purchase of Property, Plant & Equipment	-3.58	-19	-84	-19	-30	-60
Other Investing Activities, net	-0.10	-0.09	-0.07	8.34	12	0.00
Net Cash From Financing Activities	30	104	181	29	-1.73	93
Net Cash From Continuing Financing Activities	30	104	183	29	-1.73	93
Repayment of Debt	-4.78	-0.21	-0.88	-1.43	-1.73	-1.80
Issuance of Debt	4.43	3.02	33	31	0.00	95
Cash Interest Received	-	-	-	1.62	1.37	1.10

No quarterly cash flow statements for NOVONIX are available.

This table presents NOVONIX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	6/30/2020	6/30/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	52	152	277	263	226	283
Total Current Assets	28	108	116	89	57	89
Cash & Equivalents	27	103	99	79	43	80
Short-Term Investments	0.00	0.00	16	17	0.00	0.00
Accounts Receivable	0.74	1.63	2.85	3.56	8.16	2.12
Inventories, net	0.94	2.09	3.17	2.00	1.38	2.18
Prepaid Expenses	0.10	1.91	1.96	1.86	1.70	0.71
Plant, Property, & Equipment, net	6.62	24	125	140	149	175
Plant, Property & Equipment, gross	6.62	24	125	140	149	175
Total Noncurrent Assets	17	20	19	18	19	19
Intangible Assets	13	12	12	12	12	12
Other Noncurrent Operating Assets	4.03	7.93	7.30	5.74	7.51	6.93
Total Liabilities & Shareholders' Equity	52	152	277	263	226	283
Total Liabilities	7.23	14	51	79	89	121
Total Current Liabilities	3.99	4.02	8.47	37	46	84
Short-Term Debt	0.19	0.21	1.09	30	32	69
Accounts Payable	2.47	3.27	6.95	5.76	8.52	13
Current Deferred & Payable Income Tax Liabilities	-	-	0.00	0.11	0.03	0.22
Other Current Liabilities	1.33	0.54	0.43	1.50	6.02	0.72
Total Noncurrent Liabilities	3.24	9.84	43	42	42	38
Long-Term Debt	1.33	4.49	35	35	33	32
Capital Lease Obligations	1.91	5.35	4.83	4.48	6.49	5.91
Other Noncurrent Operating Liabilities	0.00	0.00	3.00	3.00	3.00	0.00
Total Equity & Noncontrolling Interests	45	138	226	184	138	162
Total Preferred & Common Equity	45	138	226	184	138	162
Total Common Equity	45	138	226	184	138	162
Common Stock	72	168	338	338	368	485
Retained Earnings	-45	-59	-139	-185	-260	-352
Other Equity Adjustments	18	30	27	30	30	29

No quarterly balance sheets for NOVONIX are available.

This table displays calculated financial ratios and metrics derived from NOVONIX's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	6/30/2020	6/30/2021	6/30/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	109.52%	-4,452.53%	188.42%	-23.81%	151.50%
EBITDA Growth	0.00%	3.67%	-224.51%	-5.50%	-26.86%	-0.62%
EBIT Growth	0.00%	0.92%	-225.34%	-6.18%	-23.85%	-0.58%
NOPAT Growth	0.00%	-0.49%	-265.68%	-0.80%	-8.86%	-24.19%
Net Income Growth	0.00%	-0.12%	-285.68%	10.82%	-61.78%	-23.93%
EPS Growth	0.00%	60.00%	-175.00%	18.18%	-66.67%	6.67%
Operating Cash Flow Growth	0.00%	-62.36%	-380.18%	-38.13%	0.04%	118.72%
Free Cash Flow Firm Growth	0.00%	0.00%	-284.59%	64.25%	-8.79%	-51.12%
Invested Capital Growth	0.00%	115.78%	210.21%	8.57%	8.57%	13.56%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	0.00%	-3,294.96%	0.00%	-330.64%	-529.24%	-232.27%
EBITDA Margin	0.00%	-7,759.22%	0.00%	-690.25%	-1,191.29%	-476.61%
Operating Margin	0.00%	-8,524.88%	0.00%	-816.44%	-1,166.46%	-575.98%
EBIT Margin	0.00%	-8,564.71%	0.00%	-768.70%	-1,290.52%	-516.09%
Profit (Net Income) Margin	0.00%	-8,564.71%	0.00%	-765.39%	-1,625.14%	-800.79%
Tax Burden Percent	100.00%	100.00%	100.00%	99.57%	100.13%	100.03%
Interest Burden Percent	98.96%	100.00%	118.55%	100.00%	125.76%	155.12%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-27.90%	0.00%	-23.26%	-23.32%	-26.91%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-20.86%	0.00%	-2.53%	-8,359.85%	-219.89%
Return on Net Nonoperating Assets (RNNOA)	0.00%	13.20%	0.00%	0.70%	-23.22%	-35.06%
Return on Equity (ROE)	-30.16%	-14.70%	-28.46%	-22.56%	-46.54%	-61.97%
Cash Return on Invested Capital (CROIC)	0.00%	-101.23%	-138.88%	-31.48%	-31.54%	-39.61%
Operating Return on Assets (OROA)	0.00%	-13.18%	0.00%	-17.18%	-24.28%	-23.48%
Return on Assets (ROA)	0.00%	-13.18%	0.00%	-17.10%	-30.57%	-36.43%
Return on Common Equity (ROCE)	-30.16%	-14.70%	-28.46%	-22.56%	-46.54%	-61.97%
Return on Equity Simple (ROE_SIMPLE)	-30.16%	-9.71%	-22.94%	0.00%	-54.38%	0.00%
Net Operating Profit after Tax (NOPAT)	-9.32	-9.37	-34	-35	-38	-47
NOPAT Margin	0.00%	-5,967.42%	0.00%	-571.51%	-816.52%	-403.19%
Net Nonoperating Expense Percent (NNEP)	-17.66%	-7.04%	-19.97%	-20.73%	8,336.53%	192.98%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-13.65%	-17.58%	-17.38%
Cost of Revenue to Revenue	0.00%	3,394.96%	0.00%	430.64%	629.24%	332.27%
SG&A Expenses to Revenue	0.00%	1,815.84%	0.00%	312.19%	432.65%	191.80%
R&D to Revenue	0.00%	1,333.18%	0.00%	95.17%	105.33%	48.97%
Operating Expenses to Revenue	0.00%	5,229.93%	0.00%	485.80%	637.22%	343.71%
Earnings before Interest and Taxes (EBIT)	-14	-13	-44	-46	-59	-60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-13	-12	-40	-42	-55	-55
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	5.13	6.39	3.05
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	5.49	7.00	3.30
Price to Revenue (P/Rev)	0.00	0.00	0.00	156.28	191.08	42.63
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	5.94	5.44	2.82
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	151.93	198.40	44.97
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	163.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.08	0.07	0.18	0.38	0.55	0.66
Long-Term Debt to Equity	0.07	0.07	0.18	0.21	0.29	0.23
Financial Leverage	-0.52	-0.63	-0.48	-0.28	0.00	0.16
Leverage Ratio	1.16	1.12	1.18	1.32	1.52	1.70
Compound Leverage Factor	1.15	1.12	1.40	1.32	1.91	2.64
Debt to Total Capital	7.16%	6.77%	15.35%	27.29%	35.67%	39.82%
Short-Term Debt to Total Capital	0.39%	0.14%	0.41%	11.82%	17.32%	25.79%
Long-Term Debt to Total Capital	6.76%	6.63%	14.94%	15.47%	18.36%	14.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	92.84%	93.23%	84.65%	72.71%	64.33%	60.18%
Debt to EBITDA	-0.27	-0.82	-1.04	-1.66	-1.39	-1.94
Net Debt to EBITDA	1.84	7.60	1.89	0.63	-0.62	-0.49
Long-Term Debt to EBITDA	-0.26	-0.81	-1.01	-0.94	-0.72	-0.68
Debt to NOPAT	-0.37	-1.07	-1.20	-2.00	-2.03	-2.29
Net Debt to NOPAT	2.49	9.88	2.18	0.76	-0.90	-0.58
Long-Term Debt to NOPAT	-0.35	-1.05	-1.16	-1.13	-1.04	-0.81
Altman Z-Score	0.00	0.00	0.00	5.83	3.57	0.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	7.14	26.92	13.72	2.39	1.24	1.07
Quick Ratio	6.88	25.93	13.98	2.66	1.10	0.98
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-34	-131	-47	-51	-69
Operating Cash Flow to CapEx	-104.76%	-31.23%	-34.93%	-210.48%	-135.15%	5.30%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	-2.09
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.10
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-1.73
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.02	0.02	0.05
Accounts Receivable Turnover	0.00	0.13	0.00	1.88	0.79	2.25
Inventory Turnover	7.59	3.52	7.69	10.07	17.12	21.57
Fixed Asset Turnover	0.00	0.01	0.00	0.05	0.03	0.07
Accounts Payable Turnover	2.89	1.86	3.95	4.09	4.06	3.52
Days Sales Outstanding (DSO)	0.00	2,758.76	0.00	193.65	464.67	161.94
Days Inventory Outstanding (DIO)	48.08	103.66	47.46	36.24	21.32	16.92
Days Payable Outstanding (DPO)	126.37	196.60	92.38	89.17	89.98	103.62
Cash Conversion Cycle (CCC)	0.00	2,665.82	0.00	140.71	396.01	75.25
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	21	46	142	155	168	185
Invested Capital Turnover	0.00	0.00	0.00	0.04	0.03	0.07
Increase / (Decrease) in Invested Capital	0.00	25	96	12	13	22
Enterprise Value (EV)	0.00	0.00	0.00	918	913	521
Market Capitalization	0.00	0.00	0.00	944	880	494
Book Value per Share	$0.33	$0.38	$0.49	$0.38	$0.28	$0.33
Tangible Book Value per Share	$0.23	$0.34	$0.46	$0.35	$0.26	$0.31
Total Capital	48	148	267	253	214	269
Total Debt	3.43	10	41	69	76	107
Total Long-Term Debt	3.24	9.84	40	39	39	38
Net Debt	-23	-93	-75	-26	34	27
Capital Expenditures (CapEx)	3.58	19	84	19	30	60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.01	1.81	-6.76	-14	5.54	-4.97
Debt-free Net Working Capital (DFNWC)	25	104	109	82	48	75
Net Working Capital (NWC)	24	104	108	52	11	5.60
Net Nonoperating Expense (NNE)	4.11	4.08	18	12	37	46
Net Nonoperating Obligations (NNO)	-23	-93	-84	-29	30	23
Total Depreciation and Amortization (D&A)	0.93	1.26	4.21	4.74	4.57	4.57
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	1,155.87%	0.00%	-224.94%	120.23%	-42.92%
Debt-free Net Working Capital to Revenue	0.00%	66,506.98%	0.00%	1,353.56%	1,044.58%	646.82%
Net Working Capital to Revenue	0.00%	66,374.50%	0.00%	858.80%	240.12%	48.37%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	464.44M	487.47M	496.86M	681.68M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.11)	($0.09)	($0.15)	($0.14)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	464.44M	487.47M	496.86M	681.68M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	485.95M	488.73M	488.73M	840.07M
Normalized Net Operating Profit after Tax (NOPAT)	-9.22	-7.97	-34	-35	-38	-42
Normalized NOPAT Margin	0.00%	-5,074.63%	0.00%	-571.51%	-816.52%	-358.76%
Pre Tax Income Margin	0.00%	-8,564.71%	0.00%	-768.70%	-1,623.02%	-800.57%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-1.81
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-1.42
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-3.64
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-3.24
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-6.15%	-43.81%	-0.27%	0.00%	-1.71%	0.00%

No quarterly metrics and ratios for NOVONIX are available.

Financials Breakdown Chart

NOVONIX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NOVONIX's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

NOVONIX's net income appears to be on an upward trend, with a most recent value of -$92.73 million in 2025, rising from -$13.43 million in 2020. The previous period was -$74.82 million in 2024. See where experts think NOVONIX is headed by visiting NOVONIX's forecast page.

NOVONIX's total operating income in 2025 was -$66.69 million, based on the following breakdown:

Total Gross Profit: -$26.90 million
Total Operating Expenses: $39.80 million

Over the last 5 years, NOVONIX's total revenue changed from -$1.65 million in 2020 to $11.58 million in 2025, a change of -802.1%.

NOVONIX's total liabilities were at $121.25 million at the end of 2025, a 37.0% increase from 2024, and a 1,576.8% increase since 2020.

In the past 5 years, NOVONIX's cash and equivalents has ranged from $26.69 million in 2020 to $102.60 million in 2021, and is currently $79.87 million as of their latest financial filing in 2025.

Over the last 5 years, NOVONIX's book value per share changed from 0.33 in 2020 to 0.33 in 2025, a change of 1.0%.

Related Companies

Financial statements for NASDAQ:NVX last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NOVONIX (NVX) Financials

Financials Breakdown Chart

NOVONIX Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NOVONIX (NVX) Financials

Annual Income Statements for NOVONIX

Quarterly Income Statements for NOVONIX

Annual Cash Flow Statements for NOVONIX

Quarterly Cash Flow Statements for NOVONIX

Annual Balance Sheets for NOVONIX

Quarterly Balance Sheets for NOVONIX

Annual Metrics And Ratios for NOVONIX

Quarterly Metrics And Ratios for NOVONIX

Financials Breakdown Chart

NOVONIX Financials - Frequently Asked Questions

When does NOVONIX's fiscal year end?

How has NOVONIX's net income changed over the last 5 years?

What is NOVONIX's operating income?

How has NOVONIX's revenue changed over the last 5 years?

How much debt does NOVONIX have?

How much cash does NOVONIX have?

How has NOVONIX's book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools